SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-19-003065
Filing Date
2019-04-17
Accepted
2019-04-17 17:17:45
Documents
3
Period of Report
2019-04-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 36021
2 EX-10.1 ex-10d1.htm EX-10.1 21897
3 GRAPHIC ex-10d1g001.jpg GRAPHIC 21187
  Complete submission text file 0001558370-19-003065.txt   88578
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

IRS No.: 481293684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33818 | Film No.: 19753744
SIC: 3845 Electromedical & Electrotherapeutic Apparatus